Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Apligraf scheduled for FDA advisory panel review

Dec. 24, 1997

Life Medical Sciences terminates Piliel trials early; refocuses R&D efforts

Dec. 22, 1997

Antiacne activity of oral contraceptives

Dec. 19, 1997

AEterna's psoriasis agent moves to phase I/II in Canada

Dec. 18, 1997

First biologic approved for treatment of diabetic foot ulcers

Dec. 18, 1997

PAF antagonist demonstrates antipruritic activity in patients with atopic dermatitis

Dec. 18, 1997

First U.S. trials of Zemaphyte to begin

Dec. 17, 1997

Once-daily tacalcitol vs. twice-daily calcipotriol for chronic plaque psoriasis

Dec. 17, 1997

Bard to distribute ProCyte's wound care products

Dec. 17, 1997

Gliatech's ADCON-L recommended for approval

Dec. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...